Novel Therapies for Unmet Clinical Needs in Myelodysplastic Syndromes

SIMPLE SUMMARY: Several novel therapies are being developed to improve the management of patients with myelodysplastic syndromes. They include drugs aimed at improving hematopoiesis and differentiation of myeloid precursors, hypomethylating agents, several compounds that target intracellular molecul...

Descripción completa

Detalles Bibliográficos
Autores principales: Cassanello, Giulio, Pasquale, Raffaella, Barcellini, Wilma, Fattizzo, Bruno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562187/
https://www.ncbi.nlm.nih.gov/pubmed/36230864
http://dx.doi.org/10.3390/cancers14194941

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562187/
https://www.ncbi.nlm.nih.gov/pubmed/36230864
http://dx.doi.org/10.3390/cancers14194941

Ejemplares similares